Wansong Lin

943 total citations
35 papers, 653 citations indexed

About

Wansong Lin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Wansong Lin has authored 35 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Immunology and 13 papers in Oncology. Recurrent topics in Wansong Lin's work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (7 papers). Wansong Lin is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (7 papers). Wansong Lin collaborates with scholars based in China, Australia and Hong Kong. Wansong Lin's co-authors include Yunbin Ye, Xu Lin, Wannan Chen, Zhifeng Zhou, Qingling Huang, Jianyin Lin, Jieyu Li, Qiaojia Huang, Jianji Pan and Jingfeng Zong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of Controlled Release.

In The Last Decade

Wansong Lin

34 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wansong Lin China 16 387 233 209 163 95 35 653
Galina M. Kiriakova United States 10 380 1.0× 210 0.9× 310 1.5× 169 1.0× 54 0.6× 11 707
Tsung‐Chieh Shih Taiwan 15 508 1.3× 233 1.0× 102 0.5× 179 1.1× 43 0.5× 20 725
Ankur Sharma United States 14 365 0.9× 128 0.5× 227 1.1× 83 0.5× 84 0.9× 37 686
Jin‐Qiu Chen United States 10 313 0.8× 86 0.4× 282 1.3× 131 0.8× 43 0.5× 17 602
Tze‐Sian Chan Taiwan 11 377 1.0× 171 0.7× 276 1.3× 83 0.5× 40 0.4× 22 627
Misty Shuo Zhang Hong Kong 10 467 1.2× 283 1.2× 147 0.7× 72 0.4× 63 0.7× 13 681
Samuel J. Vidal United States 7 473 1.2× 217 0.9× 308 1.5× 73 0.4× 65 0.7× 12 798
Hongxia Li China 14 337 0.9× 247 1.1× 126 0.6× 62 0.4× 61 0.6× 39 575
May S. Li Hong Kong 6 406 1.0× 152 0.7× 111 0.5× 94 0.6× 76 0.8× 6 625
Romain Donné France 6 267 0.7× 147 0.6× 127 0.6× 116 0.7× 90 0.9× 8 598

Countries citing papers authored by Wansong Lin

Since Specialization
Citations

This map shows the geographic impact of Wansong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wansong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wansong Lin more than expected).

Fields of papers citing papers by Wansong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wansong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wansong Lin. The network helps show where Wansong Lin may publish in the future.

Co-authorship network of co-authors of Wansong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wansong Lin. A scholar is included among the top collaborators of Wansong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wansong Lin. Wansong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chuanzhong, Ling Wang, Changhua Zhuo, et al.. (2025). ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion. Proceedings of the National Academy of Sciences. 122(15). e2423490122–e2423490122. 1 indexed citations
2.
Zhang, Lingyu, Wansong Lin, Zhifeng Zhou, et al.. (2025). Synergistic blockade of SHP-2 and A2AR signal pathways with targeted nanoparticles restores anti-tumor immunity of CD8+ T cells. Journal of Controlled Release. 384. 113889–113889.
3.
Wang, Ling, Chuanzhong Huang, Wansong Lin, et al.. (2024). EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway. Annals of Hepatology. 30(1). 101564–101564. 3 indexed citations
4.
Lin, Wansong, et al.. (2024). IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells. Experimental Cell Research. 439(1). 114073–114073. 2 indexed citations
5.
Zhu, Chenlu, Fang Liu, Wansong Lin, et al.. (2024). BCL2A1 neoepitope–elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer. Journal of Leukocyte Biology. 116(3). 601–610. 1 indexed citations
6.
Zhou, Zhifeng, et al.. (2024). Exosomal transfer of HCC-derived miR-17-5p downregulates NK cell function by targeting RUNX1-NKG2D axis. International Immunopharmacology. 136. 112361–112361. 11 indexed citations
7.
Liu, Fang, Shuping Chen, Zhifeng Zhou, et al.. (2023). Altered HLA‐A2‐restricted TP53 epitope induces specific CTL cytotoxicity against hepatocellular carcinoma. European Journal of Immunology. 53(5). e2250054–e2250054. 5 indexed citations
8.
Lin, Wansong, Jie Lin, Jieyu Li, et al.. (2022). Kindlin-2–miR-1258–TCF4 feedback loop promotes hepatocellular carcinoma invasion and metastasis. Journal of Gastroenterology. 57(5). 372–386. 9 indexed citations
9.
Zhou, Zhifeng, et al.. (2022). Altered MUC1 epitope-specific CTLs: A potential target for immunotherapy of pancreatic cancer. Journal of Leukocyte Biology. 112(6). 1577–1590. 4 indexed citations
10.
Yu, Huahui, Jieyu Li, Yuan Yuan, et al.. (2021). Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers. Cancer Biology and Medicine. 18(-). 0–0. 2 indexed citations
11.
Li, Jieyu, et al.. (2020). Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy. Cellular Immunology. 349. 104042–104042. 51 indexed citations
12.
Lu, Tianzhu, Yiping Chen, Jieyu Li, et al.. (2020). <p>High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma</p>. OncoTargets and Therapy. Volume 13. 1757–1765. 11 indexed citations
13.
Lin, Jie, et al.. (2018). MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial–mesenchymal transition. Clinical and Experimental Medicine. 18(4). 523–533. 30 indexed citations
14.
Lin, Cheng, Jingfeng Zong, Wansong Lin, et al.. (2018). EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Journal of Experimental & Clinical Cancer Research. 37(1). 283–283. 72 indexed citations
15.
Lin, Wansong, Mei Feng, Guilin Chen, et al.. (2017). Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing. Oncology Reports. 37(3). 1477–1486. 7 indexed citations
16.
Lin, Wansong, Mei Feng, Xiuhua Li, et al.. (2017). Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing. Molecular Medicine Reports. 16(2). 2075–2088. 16 indexed citations
17.
Lin, Wansong, Chuanzhong Huang, Jieyu Li, et al.. (2014). Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo. Oncology Reports. 32(1). 79–88. 17 indexed citations
18.
Lin, Wansong, et al.. (2011). Hepatitis B virus X protein enhances activation of nuclear factor κB through interaction with valosin-containing protein. Archives of Virology. 156(11). 2015–2021. 18 indexed citations
19.
Huang, Qiaojia, Qingling Huang, Wansong Lin, Jianyin Lin, & Xu Lin. (2010). Potential roles for PA28β in gastric adenocarcinoma development and diagnosis. Journal of Cancer Research and Clinical Oncology. 136(8). 1275–1282. 13 indexed citations
20.
Huang, Qiaojia, Qingling Huang, Wannan Chen, et al.. (2008). Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. Journal of Cancer Research and Clinical Oncology. 134(11). 1219–1227. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Galina M. Kiriakova Breakdown of academic impact, for papers by Tsung‐Chieh Shih Breakdown of academic impact, for papers by Ankur Sharma Breakdown of academic impact, for papers by Jin‐Qiu Chen Breakdown of academic impact, for papers by Tze‐Sian Chan Breakdown of academic impact, for papers by Misty Shuo Zhang Breakdown of academic impact, for papers by Samuel J. Vidal Breakdown of academic impact, for papers by Hongxia Li Breakdown of academic impact, for papers by May S. Li Breakdown of academic impact, for papers by Romain Donné
Rankless by CCL
2026